HUS’s group home for persons living on ventilators to be closed next year
1.10.2024 14:28:50 EEST | HUS | Press release
HUS can no longer continue the operation of its group home located in Rekola, Vantaa because it cannot organize or provide social welfare services.
With the renewal of the Disability Services Act, the responsibility for organizing the services of persons living on ventilators will be transferred from healthcare to social welfare on 1 January 2025. However, HUS will be responsible for the specialized healthcare of persons living on ventilators also in future.
The Act on Client Charges in Healthcare and Social Welfare has a transitional provision that applies to respiratory paralysis patients receiving services in the current service system. According to this provision, the patient can during a transition period of three years choose the time point for transferring from one service system to another. Patients must transfer to the service system within the scope of the new Act on 1 January 2028 at the latest.
Changes to staff’s job descriptions and tasks
HUS wants to ensure that the transition of patient living on ventilators from one service system to another will take place as smoothly as possible and with respect to the patient’s right to choose. Because it is not possible for HUS to continue operation in the Rekola group home, it will ensure in cooperation with the patients and social welfare that the continuation of care will be secured.
For the staff working in the group home, the discontinuation of the operation will mean changes to their job descriptions and tasks. Cooperation negotiations will be held with the staff and an active dialogue will be conducted with them about the changing situation.
The aim of legislation on disability services has been to strengthen the right to self-determination and the status of persons living on ventilators in relation to other people with disabilities. The residents of the Rekola group home have themselves chosen this form of housing. HUS will take into consideration the patient’s wishes in the housing arrangements. Negotiations with regard to this will continue with the parties responsible for the residents’ social services.
The staff and residents have been informed about the change in the situation.
Contacts
Mika LaineDirector, Heart and Lung Center
Tel:+358 50 427 9008mika.laine@hus.fiHanna ImmonenNurse Director, Heart and Lung Center
Tel:+358 50 463 9518hanna.immonen@hus.fiAbout HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Mekanismerna bakom ruptur av hjärnaneurysm preciseras – HUS medverkar i en internationell studie6.7.2026 07:39:02 EEST | Pressmeddelande
HUS Helsingfors universitetssjukhus medverkar i en internationell studie som tillför ny information om varför en del hjärnaneurysm rupturerar. Resultaten kan i framtiden bidra till att bättre än i nuläget identifiera aneurysmen med störst rupturrisk och stödja utvecklingen av nya läkemedelsbehandlingar. Studien har publicerats i den ansedda tidskriften Nature Neuroscience.
Aivovaltimopullistuman puhkeamisen mekanismi tarkentuu – HUS mukana kansainvälisessä tutkimuksessa6.7.2026 07:39:02 EEST | Tiedote
HUS Helsingin yliopistollinen sairaala oli mukana kansainvälisessä tutkimuksessa, joka tuo uutta tietoa siihen, miksi osa aivovaltimopullistumista puhkeaa. Tulokset voivat tulevaisuudessa auttaa tunnistamaan nykyistä paremmin ne pullistumat, joiden puhkeamisriski on suurin ja tukemaan uusien lääkehoitojen kehittämistä. Tutkimus on julkaistu arvostetussa Nature Neuroscience -lehdessä.
Arbetet för babyvänlig verksamhet fortsätter – utvecklingsarbetet fortsätter med ny sammansättning2.7.2026 10:28:59 EEST | Pressmeddelande
Efter att Institutet för hälsa och välfärd THL:s nationella samordnande upphörde fortsätter arbetet för babyvänlig verksamhet i samarbete med alla välfärdsområden. Målet för den sakkunniggrupp som HUS har sammankallat är att trygga och utveckla babyvänlig vård i hela landet.
Vauvamyönteinen työ jatkuu – kehittämistyö jatkuu uudella kokoonpanolla2.7.2026 10:28:59 EEST | Tiedote
THL:n kansallisen koordinaation päätyttyä vauvamyönteisyystyö jatkuu yhteistyössä kaikkien hyvinvointialueiden kanssa. HUSin koollekutsuman asiantuntijaryhmän tavoitteena on turvata ja kehittää vauvamyönteistä hoitoa koko maassa.
Blodprov underlättar diagnostiken av lymfkörtelinflammationer i halsområdet hos barn1.7.2026 08:54:42 EEST | Pressmeddelande
En studie som genomförts vid HUS har bekräftat tillförlitligheten hos en blodprovsbaserad diagnostisk metod för lymfkörtelinflammationer i halsområdet hos barn som orsakas av miljömykobakterier. Ett blodprov är ett snabbare och för patienten mer skonsamt sätt att säkerställa diagnosen än invasiva metoder, såsom vävnadsprovtagning.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom